TY - JOUR KW - Animals KW - Cytokines KW - Humans KW - Immunity, Cellular KW - Killer Cells, Natural KW - leprosy KW - Lymphocyte Activation KW - Lymphokines KW - Mice KW - Phagocytes KW - T-Lymphocytes AU - Kaplan G AU - Cohn Z A AB -
The intradermal injection of the purified protein derivative of tuberculin into lepromatous leprosy patients leads to a local cell-mediated immune response and to the extensive destruction of Mycobacterium leprae. This local response also occurs after intradermal injection of recombinant human interleukin-2; when administered over an 8-day period interleukin-2 evokes a systemic cell-mediated immune response and a reduction in the bacillary burden.
BT - Current opinion in immunology C1 - http://www.ncbi.nlm.nih.gov/pubmed/2054116?dopt=Abstract DA - 1991 Feb DO - 10.1016/0952-7915(91)90083-d IS - 1 J2 - Curr. Opin. Immunol. LA - eng N2 -The intradermal injection of the purified protein derivative of tuberculin into lepromatous leprosy patients leads to a local cell-mediated immune response and to the extensive destruction of Mycobacterium leprae. This local response also occurs after intradermal injection of recombinant human interleukin-2; when administered over an 8-day period interleukin-2 evokes a systemic cell-mediated immune response and a reduction in the bacillary burden.
PY - 1991 SP - 91 EP - 6 T2 - Current opinion in immunology TI - Leprosy and cell-mediated immunity. VL - 3 SN - 0952-7915 ER -